XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.3
EARNINGS (LOSS) PER SHARE
 9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER SHARE EARNINGS (LOSS) PER SHARE
Earnings (loss) per share attributable to Bausch Health Companies Inc. is calculated as follows:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions, except per share amounts)2025202420252024
Net income (loss) attributable to Bausch Health Companies Inc.$179 $(85)$269 $(139)
Basic weighted-average common shares outstanding371.3 368.4 370.6 367.7 
Diluted effect of stock options and RSUs4.2 — 3.5 — 
Diluted weighted-average common shares outstanding375.5 368.4 374.1 367.7 
Earnings (loss) per share attributable to Bausch Health Companies Inc.
Basic$0.48 $(0.23)$0.73 $(0.38)
Diluted$0.48 $(0.23)$0.72 $(0.38)
During the three and nine months ended September 30, 2024, all potential common shares issuable for stock options and RSUs were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options and RSUs on the weighted-average number of common shares outstanding would have been approximately 2,245,000 and 2,656,000 common shares for the three and nine months ended September 30, 2024.
During the three and nine months ended September 30, 2025, time-based RSUs, performance-based RSUs and stock options to purchase approximately 7,180,000 and 7,234,000 common shares, respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method.
During the three and nine months ended September 30, 2024, time-based RSUs, performance-based RSUs and stock options to purchase approximately 14,554,000 and 14,416,000 common shares, respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method.
During the three and nine months ended September 30, 2025, an additional 2,028,000 performance-based RSUs were not included in the computation of diluted earnings per share as the required performance conditions had not been met.